Intratio
Loading...
Skip to main content
Model output · Signal date 2026-10-16

Onemednet Corp (ONMD) Stock Forecast Oct. 16, 2026

Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq

Follow Unlock full AI forecasts
Rating · 90D ▲ Bullish Exact rating locked
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage Top 35% of 5172 stocks scored
Rank correlation · 90D -14.0% Spearman, 357 dates
Market Cap $28M small-cap · #10 of 15 peers
Summary

Onemednet Corp (ONMD) stock forecast summary

Our AI ranks Onemednet Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Onemednet Corp is a small-cap company with a market capitalization of $28M. It ranks number 10 by market capitalization among the 15 Services-Commercial Physical & Biological Research issuers in our coverage with a current forecast.

For ONMD, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -14.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, ONMD included.

Follow ONMD free
Price

ONMD price chart and AI forecast

ONMD
Cross-section · 2026-10-16

How ONMD ranks among 5172 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-06-30

Onemednet Corp (ONMD) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Commercial Physical & Biological Research peers listed below that report each metric.

Valuation & Market

MetricONMDIndustry medianRank
Market Cap $28M $446M 10/15
EPS $-0.10 – –

Profitability & Margins

MetricONMDIndustry medianRank
Gross Margin -63.2% 33.0% 6/7
Operating Margin -875.3% -125.8% 11/13
EBT Margin -383.4% -114.8% 11/13

Financial Health

MetricONMDIndustry medianRank
Current Ratio 0.28x 0.78x 12/16
Interest Coverage -255.2x -2.7x 10/13
Working Capital -$3M -$1M 11/15

Cash Flow

MetricONMDIndustry medianRank
Operating Cash Flow -$9M -$280K 10/15

Income Statement

MetricONMDIndustry medianRank
Operating Income -$12M -$390K 11/15
R&D Expense $2M $17M 5/7
SG&A Expense $14M $41M 8/12
Cost of Goods Sold $2M $4M 5/8

Dividend & Shareholder Information

MetricONMDIndustry medianRank
Shares Outstanding 6M – –

Balance Sheet Highlights (USD millions)

Total Current Assets$1M
Cash & Short-term Investments$360K
Accounts Receivable$660K
Total Liabilities$5M
Quarterly Financial Reports

ONMD quarterly financials and insider trading

Industry Peers · Services-Commercial Physical & Biological Research

Onemednet Corp (ONMD) industry peers

Companies classified under the same SEC industry code as Onemednet Corp (Services-Commercial Physical & Biological Research): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
ONMD Onemednet Corp ▲ $28M – –
IQV Iqvia Holdings Inc. ▼ $45.37B 33.2x 7.3x
INCY Incyte Corp ▶ $22.20B 16.0x 4.0x
MEDP Medpace Holdings, Inc. ▼ $17.26B 36.3x 39.8x
CRL Charles River Laboratories International, Inc. ▶ $14.33B – 5.1x
ICLR Icon Plc ▶ $13.13B 36.8x 1.4x
ABSI Absci Corp ▲ $1.42B – 7.1x
OABI Omniab, Inc. ▲ $667M – 2.6x
NRC Nrc Health ▲ $446M – –
MXCT Maxcyte, Inc. ▲ $134M – 0.9x
VSBC Vitaspring Biomedical Co. Ltd. ▼ $7M – –
BIAF Bioaffinity Technologies, Inc. ▼ $5M – 1.3x
BUDZ Weed, Inc. ▲ $3M – –
ISPC Ispecimen Inc. ▼ $2M – 1.3x
FOXO Foxo Technologies Inc. ▼ $180K – –
CBIH Cannabis Bioscience International Holdings, Inc. ▼ N/A – –

Where ONMD sits on the market map

Industrial Applications and Services · Services-Commercial Physical & Biological Research
Explore the map →
News

Onemednet Corp (ONMD) stock news

Loading...

FAQ

Onemednet Corp (ONMD) stock forecast FAQ

What is the Onemednet Corp (ONMD) stock forecast?

Our AI ranks Onemednet Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

How accurate are Onemednet Corp stock predictions?

For ONMD, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -14.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Onemednet Corp forecasts updated?

Onemednet Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.

Which companies are Onemednet Corp's industry peers?

16 issuers in our coverage, ONMD included, share the SEC industry code Services-Commercial Physical & Biological Research. The largest are: Iqvia Holdings Inc. (IQV), Incyte Corp (INCY), Medpace Holdings, Inc. (MEDP), Charles River Laboratories International, Inc. (CRL), Icon Plc (ICLR), Absci Corp (ABSI).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.